As of 2025-05-22, the Intrinsic Value of Isofol Medical AB (publ) (ISOFOL.ST) is -3.06 SEK. This ISOFOL.ST valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.20 SEK, the upside of Isofol Medical AB (publ) is -354.76%.
Based on its market price of 1.20 SEK and our intrinsic valuation, Isofol Medical AB (publ) (ISOFOL.ST) is overvalued by 354.76%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -3.06 - -3.06 | -3.06 | -354.76% |
| P/E | (5.66) - (7.29) | (7.26) | -705.2% |
| DDM - Stable | (2.46) - (9.88) | (6.17) | -613.9% |
| DDM - Multi | (2.16) - (6.99) | (3.33) | -377.2% |
| Market Cap (mil) | 193.82 |
| Beta | 1.23 |
| Outstanding shares (mil) | 161.52 |
| Enterprise Value (mil) | 97.67 |
| Market risk premium | 5.10% |
| Cost of Equity | 9.06% |
| Cost of Debt | 5.00% |
| WACC | 6.51% |